Customer Care Center


Dotarem® (gadoterate meglumine) Injection is approved in the US for intravenous use and is the first and only macrocyclic and ionic gadolinium-based contrast agent in USA. See Dotarem Prescribing Information


Learn more


Guerbet has acquired the Ethiodol® NDA from Nycomed US Inc. effective May 7, 2010 and is working with the FDA to resume manufacturing of Ethiodol® in the near future to ensure continued availability for the US patients.


Learn more

Sales Representative

To find your local Imaging Sales Specialist, please enter your zip code: